Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Endocannabinoids in nervous system health and disease: the big picture in a nutshell
Stephen D. Skaper, Vincenzo Di Marzo
Philosophical Transactions of the Royal Society B Biological Sciences (2012) Vol. 367, Iss. 1607, pp. 3193-3200
Open Access | Times Cited: 114

Showing 1-25 of 114 citing articles:

Modulating the endocannabinoid system in human health and disease – successes and failures
Pál Pacher, George Kunos
FEBS Journal (2013) Vol. 280, Iss. 9, pp. 1918-1943
Open Access | Times Cited: 369
Involvement of Lipids in Alzheimer’s Disease Pathology and Potential Therapies
Hannah Chew, Victoria Solomon, Alfred N. Fonteh
Frontiers in Physiology (2020) Vol. 11
Open Access | Times Cited: 267
Does Cannabidiol Protect Against Adverse Psychological Effects of THC?
Raymond J.M. Niesink, Margriet van Laar
Frontiers in Psychiatry (2013) Vol. 4
Open Access | Times Cited: 223
Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials
Mary Lynch, Mark A. Ware
Journal of Neuroimmune Pharmacology (2015) Vol. 10, Iss. 2, pp. 293-301
Closed Access | Times Cited: 177
Anti-inflammatory ω-3 endocannabinoid epoxides
Daniel R. McDougle, Josephine E. Watson, Amr A. Abdeen, et al.
Proceedings of the National Academy of Sciences (2017) Vol. 114, Iss. 30
Open Access | Times Cited: 150
Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to neuroprotection
Sandeep Vasant More, Dong‐Kug Choi
Molecular Neurodegeneration (2015) Vol. 10, Iss. 1
Open Access | Times Cited: 134
Astrocytes in endocannabinoid signalling
Marta Navarrete, Adolfo Díez, Alfonso Araque
Philosophical Transactions of the Royal Society B Biological Sciences (2014) Vol. 369, Iss. 1654, pp. 20130599-20130599
Open Access | Times Cited: 117
Endocannabinoid Transport Revisited
Simon Nicolussi, Jürg Gertsch
Vitamins and hormones (2015), pp. 441-485
Closed Access | Times Cited: 114
Precision Nutrition and Omega-3 Polyunsaturated Fatty Acids: A Case for Personalized Supplementation Approaches for the Prevention and Management of Human Diseases
Floyd H. Chilton, Rahul Dutta, Lindsay M. Reynolds, et al.
Nutrients (2017) Vol. 9, Iss. 11, pp. 1165-1165
Open Access | Times Cited: 112
The endocannabinoid system and appetite: relevance for food reward
Gerry Jager, Renger F. Witkamp
Nutrition Research Reviews (2014) Vol. 27, Iss. 1, pp. 172-185
Open Access | Times Cited: 110
Polyunsaturated fatty acids and endocannabinoids in health and disease
Hércules Rezende Freitas, Alinny Rosendo Isaac, Renato Malcher‐Lopes, et al.
Nutritional Neuroscience (2017) Vol. 21, Iss. 10, pp. 695-714
Closed Access | Times Cited: 103
The Neuroimmunology of Chronic Pain: From Rodents to Humans
Peter M. Grace, Vivianne L. Tawfik, Camilla I. Svensson, et al.
Journal of Neuroscience (2020) Vol. 41, Iss. 5, pp. 855-865
Open Access | Times Cited: 94
Stress-induced blood brain barrier disruption: Molecular mechanisms and signaling pathways
Menizibeya O. Welcome, Nikos E. Mastorakis
Pharmacological Research (2020) Vol. 157, pp. 104769-104769
Closed Access | Times Cited: 92
Amiodarone and thyroid physiology, pathophysiology, diagnosis and management
Richard G. Trohman, Parikshit S. Sharma, Elizabeth A. McAninch, et al.
Trends in Cardiovascular Medicine (2018) Vol. 29, Iss. 5, pp. 285-295
Open Access | Times Cited: 91
Cannabinoids, inflammation, and fibrosis
Robert B. Zurier, Sumner Burstein
The FASEB Journal (2016) Vol. 30, Iss. 11, pp. 3682-3689
Closed Access | Times Cited: 87
Microglial Inflammatory-Metabolic Pathways and Their Potential Therapeutic Implication in Major Depressive Disorder
Reza Rahimian, Claudia Belliveau, Rebecca Chen, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 46
Fatty acids, endocannabinoids and inflammation
Renger F. Witkamp
European Journal of Pharmacology (2015) Vol. 785, pp. 96-107
Closed Access | Times Cited: 72
The Chemistry of Neurodegeneration: Kinetic Data and Their Implications
Matic Pavlin, Matej Repič, Robert Vianello, et al.
Molecular Neurobiology (2015) Vol. 53, Iss. 5, pp. 3400-3415
Closed Access | Times Cited: 70
Use of Cannabis and Cannabinoids for Treatment of Cancer
Viktoriia Cherkasova, Bo Wang, Marta Gerasymchuk, et al.
Cancers (2022) Vol. 14, Iss. 20, pp. 5142-5142
Open Access | Times Cited: 33
Emerging Therapeutic Potential of Cannabidiol (CBD) in Neurological Disorders: A Comprehensive Review
Kuldeep Singh, Bharat Bhushan, Dilip Kumar Chanchal, et al.
Behavioural Neurology (2023) Vol. 2023, pp. 1-17
Open Access | Times Cited: 19
Potential Therapeutic Targets to Modulate the Endocannabinoid System in Alzheimer’s Disease
Hina Kanwal, Moris Sangineto, Martina Ciarnelli, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4050-4050
Open Access | Times Cited: 7
Guineensine is a novel inhibitor of endocannabinoid uptake showing cannabimimetic behavioral effects in BALB/c mice
Simon Nicolussi, Juan Manuel Viveros–Paredes, M. Salomé Gachet, et al.
Pharmacological Research (2014) Vol. 80, pp. 52-65
Closed Access | Times Cited: 61
Endocannabinoid metabolism by cytochrome P450 monooxygenases
Susan Zelasko, William R. Arnold, Aditi Das
Prostaglandins & Other Lipid Mediators (2014) Vol. 116-117, pp. 112-123
Closed Access | Times Cited: 58
Maternal separation and early stress cause long‐lasting effects on dopaminergic and endocannabinergic systems and alters dendritic morphology in the nucleus accumbens and frontal cortex in rats
Antonio Romano‐López, Mónica Méndez‐Díaz, Fabio Garcı́a-Garcı́a, et al.
Developmental Neurobiology (2015) Vol. 76, Iss. 8, pp. 819-831
Closed Access | Times Cited: 52
Plasma concentrations of oleoylethanolamide in a primary care sample of depressed patients are increased in those treated with selective serotonin reuptake inhibitor-type antidepressants
Pablo Romero‐Sanchiz, Raquel Nogueira‐Arjona, Antoni Pastor, et al.
Neuropharmacology (2019) Vol. 149, pp. 212-220
Open Access | Times Cited: 43
Page 1 - Next Page

Scroll to top